文献速递泌尿生殖腹部MR

结合临床与影像输入的多模态人工智能提高前列腺癌检出

Multimodal AI Combining Clinical and Imaging Inputs Improves Prostate Cancer Detection.
PubMed 文献 · Invest Radiol · 2024-07-29

该研究回顾性分析2家机构932例疑似临床显著前列腺癌(ISUP≥2)的双参数前列腺MRI,将临床参数与基于MRI的深度学习模型融合构建6种多模态AI分类器,发现整合深度学习可疑度与临床特征经早期融合的模型诊断性能最优,外部验证AUC 0.77,优于仅用临床参数(0.67)或仅用深度学习可疑度(0.70),与放射科医师PI-RADS评估无显著差异。

要点

  • 多模态AI整合深度学习可疑度与临床参数,外部验证AUC 0.77,优于单模态模型。
  • 早期融合优于晚期融合,外部数据AUC 0.77 vs 0.73。
  • 加入病灶体积未提升诊断效能。

核心结论

  • 多模态AI(联合深度学习可疑度与临床参数)在临床显著前列腺癌检出上优于仅用临床参数或仅用MRI的AI,早期信息融合在多中心环境中增强了AI稳健性,纳入病灶体积未提升诊断效能。

研究设计与样本

  • 回顾性分析2家机构932例疑似临床显著前列腺癌(ISUP≥2)的双参数前列腺MRI,由既往开发的深度学习模型自动检测并分割病灶,提取深度学习可疑度、临床参数(前列腺特异性抗原、前列腺体积、年龄)和MRI病灶体积三类特征,训练6种多模态AI分类器,内部测试中心1的20%数据,外部测试中心2数据(n=529),以ROC比较确定最优特征组合与融合方法。

诊断标准与关键数值

  • 内部测试中,整合深度学习可疑度与临床特征经早期融合的多模态AI性能最高。
  • 外部测试中,多模态AI的AUC为0.77,优于仅用临床参数的0.67(P < 0.001)和仅用深度学习可疑度的0.70(P = 0.006)。
  • 外部数据中早期融合AUC 0.77优于晚期融合的0.73(P = 0.005)。
  • 多模态AI与放射科医师PI-RADS评估无显著性能差距:内部AUC 0.87 vs 0.88,外部AUC 0.77 vs 0.75,均P > 0.05。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Deep learning (DL) studies for the detection of clinically significant prostate cancer (csPCa) on magnetic resonance imaging (MRI) often overlook potentially relevant clinical parameters such as prostate-specific antigen, prostate volume, and age. This study explored the integration of clinical parameters and MRI-based DL to enhance diagnostic accuracy for csPCa on MRI.

MATERIALS AND METHODS: We retrospectively analyzed 932 biparametric prostate MRI examinations performed for suspected csPCa (ISUP ≥2) at 2 institutions. Each MRI scan was automatically analyzed by a previously developed DL model to detect and segment csPCa lesions. Three sets of features were extracted: DL lesion suspicion levels, clinical parameters (prostate-specific antigen, prostate volume, age), and MRI-based lesion volumes for all DL-detected lesions. Six multimodal artificial intelligence (AI) classifiers were trained for each combination of feature sets, employing both early (feature-level) and late (decision-level) information fusion methods. The diagnostic performance of each model was tested internally on 20% of center 1 data and externally on center 2 data (n = 529). Receiver operating characteristic comparisons determined the optimal feature combination and information fusion method and assessed the benefit of multimodal versus unimodal analysis. The optimal model performance was compared with a radiologist using PI-RADS.

RESULTS: Internally, the multimodal AI integrating DL suspicion levels with clinical features via early fusion achieved the highest performance. Externally, it surpassed baselines using clinical parameters (0.77 vs 0.67 area under the curve [AUC], P < 0.001) and DL suspicion levels alone (AUC: 0.77 vs 0.70, P = 0.006). Early fusion outperformed late fusion in external data (0.77 vs 0.73 AUC, P = 0.005). No significant performance gaps were observed between multimodal AI and radiologist assessments (internal: 0.87 vs 0.88 AUC; external: 0.77 vs 0.75 AUC, both P > 0.05).

CONCLUSIONS: Multimodal AI (combining DL suspicion levels and clinical parameters) outperforms clinical and MRI-only AI for csPCa detection. Early information fusion enhanced AI robustness in our multicenter setting. Incorporating lesion volumes did not enhance diagnostic efficacy.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Roest C, Yakar D, Rener Sitar DI, et al. Multimodal AI Combining Clinical and Imaging Inputs Improves Prostate Cancer Detection. Invest Radiol. 2024. PMID: 39074400. doi:10.1097/RLI.0000000000001102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。